Global Coagulation Markers Market to Reach $1.63 Billion by 2029, Growing at 6.9% CAGR

What Is the Expected Size and Growth Rate of the Coagulation Markers Market?
Recent years have seen a robust expansion in the market size of coagulation markers. The market which was worth $1.16 billion in 2024 is projected to increase to $1.25 billion in 2025 with a 7.1% compound annual growth rate (CAGR). The uptick in the historic phase can be linked to factors such as the escalating rates of cardiovascular ailments, an ageing demographic, the proliferation of surgical practices, heightened awareness and early detection, governmental policies and funding, as well as the broadening of the healthcare infrastructure.

There is an anticipation for significant expansion in the coagulation markers market in the upcoming years, with an expected value of $1.63 billion in 2029 growing at a compound annual growth rate (CAGR) of 6.9%. Factors contributing to this growth during the forecast period include an increased prevalence of chronic conditions, the rise in personalized healthcare, an expanding global populace, increased healthcare expenditure, and broadening reach in untapped markets. Key trends predicted for the forecast period consist of artificial intelligence and machine learning integration, the creation of innovative biomarkers, improvements in point-of-care tech, lab automation, the rise of wearable health tech, telehealth and remote patient monitoring, and the implementation of sustainable diagnostic procedures.

What Factors Are Propelling the Expansion of the Coagulation Markers Market?
Expectations are high for the expansion of the coagulation markers market, driven primarily by a surge in the incidence of blood disorders. This term covers a broad spectrum of diseases that hinder the normal functioning of the blood. The growing occurrence of these disorders can be attributed to an aging population, increased awareness, and better diagnostic facilities. Coagulation markers play a key role in the diagnosis and treatment of blood disorders. They evaluate clotting functionality, spot anomalies, and monitor how effectively treatments for conditions like hemophilia and thrombosis are working. A case in point is reported by the Australia-based Leukaemia Foundation: as of May 2024, approximately 135,000 Australians are coping with blood cancer or a blood disorder. By 2035, these figures are forecasted to surpass 275,000. Consequently, the increasing prevalence of blood disorders is fuelling the growth of the coagulation marker market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17117&type=smp

Which Leading Companies Are Shaping the Growth of the Coagulation Markers Market?
Major companies operating in the coagulation markers market are Siemens Healthineers, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Werfen Group, Nihon Kohden Corporation, Randox Laboratories Ltd, Stago Group, Sekisui Diagnostics, Helena Laboratories Italia Spa, Tulip Diagnostics Ltd, Trinity Biotech PLC, CTK Biotech Inc., International Technidyne Corporation (ITC), Diazyme Laboratories Inc., AdvaCare Pharma USA (AccuQuik Test Kits), Technoclone GmbH, BioMedica Diagnostics Inc., Eurolyser Diagnostica GmbH, Goldsite Diagnostics Inc., Hipro Biotechnology Co. Ltd., HYPHEN BioMed

What Are the Major Trends Shaping the Coagulation Markers Market?
In their efforts to enhance speed and precision in the diagnosis of blood clot-related ailments, dominant firms in the coagulation markers industry are directing their resources towards crafting technologically advanced solutions such as D-dimer kits. The kits function as diagnostic instruments that measure the quantity of D-dimer - a fragment of a protein that is produced when a blood clot dissolves. This assists in the detection and evaluation of clot-related complications like deep vein thrombosis and pulmonary embolism. An example is the launch of the Vcheck D-dimer 5Tests/Kit in July 2024 by Bionote Inc., an American biotechnology firm. The Vcheck D-dimer 5Tests/Kit is an immunodiagnostic tool created for veterinary application, supplying 5 tests in each kit to spot D-dimer levels, an indicator of the formation and decay of blood clots. Consequently, it is beneficial in identifying conditions such as thrombosis, sepsis, and DIC in veterinary clinics.

What Are the Key Segments of the Coagulation Markers Market?
The coagulation markers market covered in this report is segmented -

1) By Product: D-Dimer Assay, Fibrinogen Assay
2) By Sample Type: Plasma, Whole Blood Sample, Other Sample Types
3) By Technology: Fluorescence Immunoassay, Enzyme-Linked Immuno Sorbent Assay (ELISA), Rapid Test, Particle Enhanced Immunoturbidimetric Assay
4) By Application: Deep Venous Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Trauma, Other Applications
5) By End User: Hospital, Specialty Clinics, Academic And Research Institute, Diagnostics Laboratories

Subsegments:
1) By D-Dimer Assay: ELISA-Based D-Dimer Assay, Lateral Flow Immunoassay D-Dimer Test, Chemiluminescent Immunoassay D-Dimer Test
2) By Fibrinogen Assay: Clauss Fibrinogen Assay, Functional Fibrinogen Assay, Automated Fibrinogen Assay

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/coagulation-markers-global-market-report

Which Region Dominates the Coagulation Markers Market?
North America was the largest region in the coagulation markers market in 2024. The regions covered in the coagulation markers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Coagulation Markers Global Market Report?

- Market Size Analysis: Analyze the Coagulation Markers Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Coagulation Markers Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Coagulation Markers Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Coagulation Markers Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17117

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.